½Å¾à°³¹ß ½ÃÀåÁ¶»çº¸°í¼­

Global Information¿¡¼­´Â ÇöÀç 25°³ ÀÌ»óÀÇ ÃâÆÇ»ç¿Í ¾Ö³Î¸®½ºÆ®°¡ ¹ß°£ÇÑ 1,000°³ ÀÌ»óÀÇ ½Å¾à°³¹ß(Drug Discovery)°ü·Ã º¸°í¼­¸¦ º¸À¯Çϰí ÀÖÀ¸¸ç, ´Ù¾çÇÑ ºÐ¾ß¿Í Ç׸ñÀÇ º¸°í¼­¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇèÀ» ºñ·ÔÇØ ½Å¾à°³¹ß ±â¼ú °ü·Ã ¾Æ¿ô¼Ò½Ì¿¡ À̸£±â±îÁö ½Å¾à°³¹ß ½ÃÀåÀÇ ¸ðµç ±¹¸é¿¡ ´ëÇØ ´Ù¾çÇÑ °üÁ¡¿¡¼­ ºÐ¼®Çß½À´Ï´Ù. °í°´ÀÇ ´ÏÁî¿¡ ¸Â´Â ÃÖÀûÀÇ º¸°í¼­¸¦ ÃßÃµÇØ µå¸®°í ÀÖÀ¸´Ï ¹®ÀÇ Áֽñ⠹ٶø´Ï´Ù.

1 - 25 (Àüü: 669°Ç)
¼¼°èÀÇ Ãʱ⠵¶¼º ½ÃÇè ½ÃÀå º¸°í¼­(2025³â)
Early Toxicity Testing Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,183,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀüÀÓ»ó CRO ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ¼­ºñ½ºº°, ¸ðµ¨ À¯Çüº°, ÃÖÁ¾ ÀÌ¿ë »ê¾÷º°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Preclinical CRO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Model Type, By End-Use Industry, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,500 £Ü 6,197,000 (ºÎ°¡¼¼ º°µµ)
IDC MaturityScape º¥Ä¡¸¶Å© : AI¸¦ Ȱ¿ëÇÑ ¼¼°è »ý¸í°úÇÐ Á¶Á÷(2025³â)
IDC MaturityScape Benchmark: AI-Fueled Life Sciences Organization Worldwide, 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 7,500 £Ü 10,329,000 (ºÎ°¡¼¼ º°µµ)
IDC MaturityScape º¥Ä¡¸¶Å© : AI¸¦ Ȱ¿ëÇÑ ¼¼°è ÇコÄɾî Á¶Á÷(2025³â)
IDC MaturityScape Benchmark: AI-Fueled Healthcare Organization Worldwide, 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 7,500 £Ü 10,329,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : Á¦°øº°, ±â´Éº°, ¿ëµµº°, Àü°³ ¹æ½Äº°, Åøº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - ¿¹Ãø(-2030³â)
Artificial Intelligence(AI) in Healthcare Market by Offering(Integrated), Function(Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application(Clinical), End User(Hospitals), Region-Global Forecast to 2030
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,950 £Ü 6,817,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ À§Å¹°³¹ß»ý»ê ¾Æ¿ô¼Ò½Ì ½ÃÀå(2025-2029³â)
Global Contract Development and Manufacturing Organization Outsourcing Market 2025-2029
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 2,500 £Ü 3,443,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ãʱ⠵¶¼º ½ÃÇè ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¿¹Ãø : ±â¹ýº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Early Toxicity Testing Market Size, Share, Trends and Forecast by Technique, End User, and Region, 2025-2033
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 2,999 £Ü 4,130,000 (ºÎ°¡¼¼ º°µµ)
Á¾¾çÇÐ ±â¹Ý In-Vivo CRO ½ÃÀå º¸°í¼­ : ÀûÀÀÁõ, ¸ðµ¨, ¿ëµµ, Áö¿ªº°(2025-2033³â)
Oncology Based In-Vivo CRO Market Report by Indication (Blood Cancer, Solid Tumors, and Others), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX), and Others), Application (Hospitals, Rehabilitation Centers), and Region 2025-2033
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 2,999 £Ü 4,130,000 (ºÎ°¡¼¼ º°µµ)
ÀÓ»ó½ÃÇè °ü¸® ½Ã½ºÅÛ ½ÃÀå º¸°í¼­ : ±¸¼º¿ä¼Ò, Àü°³ ¹æ½Ä, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
Clinical Trial Management Systems Market Report by Component, Deployment Mode, End User, and Region 2025-2033
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 2,999 £Ü 4,130,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºó´ÙÄÌ ½ÃÀå º¸°í¼­(2025³â)
Vyndaqel Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,183,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼ÒÆ÷¼º ¸ð³ë¾Æ¹Î ¼ö¼Ûü 2(VMAT2) ¾ïÁ¦Á¦ ½ÃÀå º¸°í¼­(2025³â)
Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,183,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÓ»ó½ÃÇè ¼ÒÇÁÆ®¿þ¾î ½ÃÀå º¸°í¼­(2025³â)
Clinical Trial Software Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,183,000 (ºÎ°¡¼¼ º°µµ)
»ý¸í°úÇпë ÀΰøÁö´ÉÀÇ ÀνÄ
Perceptions of Artificial Intelligence in the Life Sciences
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 8,000 £Ü 11,017,000 (ºÎ°¡¼¼ º°µµ)
¹Ì±¹ÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ ½ÃÀå : ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼­ - ¿ø·áº°, ¼­ºñ½ºº°, Á¦Ç°º°, À¯Çüº°, »ç¾÷ ±Ô¸ðº°, Ä¡·á ¿µ¿ªº° ºÎ¹® ¿¹Ãø(2025-2030³â)
U.S. Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trends Analysis Report By Source, By Service, By Products, By Type, By Scale Of Operation, By Therapeutic Area, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,950 £Ü 6,817,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °íȯ¾Ï ½ÃÀå º¸°í¼­(2025³â)
Testicular Cancer Global Market Report 2025
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,490 £Ü 6,183,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÓ»ó½ÃÇè ¼­ºñ½º ½ÃÀå º¸°í¼­(2025³â)
Clinical Trial Services Global Market Report 2025
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,490 £Ü 6,183,000 (ºÎ°¡¼¼ º°µµ)
¹Ì±¹ÀÇ ÀúºÐÀÚ Çõ½Å API CDMO ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® - º´±âº°, ¼­ºñ½ºº°, °í°´ À¯Çüº°, Ä¡·á ¿µ¿ªº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Service, By Customer Type, By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,950 £Ü 6,817,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¸±·¹¹ÚŽ(Relebactam) ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Relebactam Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,850 £Ü 5,302,000 (ºÎ°¡¼¼ º°µµ)
ÀÓ»ó½ÃÇè ¿ëǰ ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - ÀÓ»ó ´Ü°èº°, Á¦Ç° ¹× ¼­ºñ½ºº°, Ä¡·á ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Clinical Trial Supplies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Clinical Phase, By Product & Services, By Therapeutic Use, By End User, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,500 £Ü 6,197,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¸»ÃʽŰ溴Áõ Ä¡·á ½ÃÀå(2025-2029³â)
Global Peripheral Neuropathy Treatment Market 2025-2029
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 2,500 £Ü 3,443,000 (ºÎ°¡¼¼ º°µµ)
ȯÀÚ À¯·¡ ÀÌÁ¾ÀÌ½ÄÆí/PDX ¸ðµ¨ ½ÃÀå ºÐ¼® ¹× ¿¹Ãø(-2034³â) : À¯Çü, Á¦Ç°, ¼­ºñ½º, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, ´Ü°è, ±¸¼º¿ä¼Ò, ÇÁ·Î¼¼½º
Patient-Derived Xenograft/PDX Model Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Stage, Component, Process
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,750 £Ü 6,541,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼¼³î¸®Æ½½º ¹× ³ëÈ­ ¹æÁö ÀǾàǰ ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® - Á¦Ç°º°, À¯Åë ä³Îº°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Senolytics And Anti-Aging Pharmaceuticals Market Size, Share & Trends Analysis Report By Product (Anti-Aging Pharmaceuticals), By Distribution Channel, By Application (Clinical Use / Off-label Therapeutics), By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 5,950 £Ü 8,194,000 (ºÎ°¡¼¼ º°µµ)
ÀÓ»ó½ÃÇè ¸ÅĪ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, Àü°³ Çüź°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Clinical Trials Matching Software Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Deployment Mode, By End-use, By Region & Competition, 2020-2030F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,500 £Ü 6,197,000 (ºÎ°¡¼¼ º°µµ)
ÇコÄÉ¾î ºÐ¾ß ¿¡ÀÌÀüÆ® AI ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Agentic AI In Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,500 £Ü 6,197,000 (ºÎ°¡¼¼ º°µµ)
°æÇǵ¶¼º ½ÃÇè ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - ½ÃÇè À¯Çüº°, ½ÃÇè ¹æ¹ý À¯Çüº°(»ýü³» ½ÃÇè°ú »ýü¿Ü ½ÃÇè), ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030F)
Dermal Toxicity Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Testing Method Type (In Vivo Testing and In Vitro Testing ), By End User, By Region & Competition, 2020-2030F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,500 £Ü 6,197,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.